SM
Sheik Mohamed Salahudeen
About Sheik Mohamed Salahudeen
Data last updated:
Sheik Mohamed Salahudeen is a Director at Tricell Biologics Private Limited (since 2017) and Designated Partner at Cms Healthcare Llp (since 2022). The companies operate in Healthcare. The largest current company by reported revenue is Tricell Biologics Private Limited at ₹4.99 Cr (FY 2024). Earlier, Sheik Mohamed Salahudeen was a Director at Salsen Clin Research Private Limited (from 2011).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tricell Biologics Private Limited U74999TN2017PTC114837 | Director | 08 Feb 2017 | 2017 | ₹4.99 Cr (FY 2024) | Active |
 Cms Healthcare Llp ABB-7688 | Designated Partner | 18 Jul 2022 | 2022 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Salsen Clin Research Private Limited U74900TN2011PTC081734 | Director | 01 Aug 2011 | 2011 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Sheik Mohamed Salahudeen
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vellore Chakrapani Surendranath | 07719931 | Tricell Biologics Private Limited | Director |
| Clement Joseph | 07069806 | Cms Healthcare Llp | Designated Partner |
| Nedunchezhian Manojmuthu | 10011516 | Cms Healthcare Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sheik Mohamed Salahudeen
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sheik Mohamed Salahudeen
Sheik Mohamed Salahudeen currently holds 2 directorships: Tricell Biologics Private Limited (Director, since 08 Feb 2017, revenue ₹4.99 Cr (FY 2024)); Cms Healthcare Llp (Designated Partner, since 18 Jul 2022).
Sheik Mohamed Salahudeen was first appointed on 01 Aug 2011 as Director at Salsen Clin Research Private Limited. The most recent appointment on record is 18 Jul 2022 at Cms Healthcare Llp.
Sheik Mohamed Salahudeen held 1 earlier board appointment: Salsen Clin Research Private Limited (Director, from 01 Aug 2011).
The current boards of Sheik Mohamed Salahudeen's companies include Vellore Chakrapani Surendranath (Tricell Biologics Private Limited), Clement Joseph (Cms Healthcare Llp), Nedunchezhian Manojmuthu (Cms Healthcare Llp).